00874 BAIYUNSHAN PH
Trading Add to PorfolioIndex Constituent : None | |||
Major Shareholders | Guangzhou Pharmaceutical Holdings Limited (45.04%) | Sector | Health Care & Biotechnology |
---|---|---|---|
Web Site | http://www.gybys.com.cn | Tel | (86 20) 6628-1011 |
sec@gybys.com.cn | Fax | (86 20) 6628-1229 | |
Related Equities | N/A | ||
Principal Activities | The Group is principally engaged in: (1) the research and development, manufacturing and sales of Chinese patent medicine, Western medicine, chemical raw materials, natural medicine, biological medicine and chemical raw materials intermediates; (2) the wholesale, retail and import and export business of Western medicine, Chinese medicine and medical equipment; (3) the research and development, production and sales of great health product; and (4) the health industry investment in medical care, health management, health maintenance and elderly care, etc. |
Consolidated List of Substantial Shareholders
Name | Number of Shares Interested | % of Issued Share Capital (%) | Date of Last Notice Filed (Y/M/D) |
---|---|---|---|
Norges Bank | 24,948,000(L) | 11.35(L) | 01/11/2018 |
Citigroup Inc. | 21,919,106(L) 438,000(S) 21,331,106(P) | 9.96(L) 0.19(S) 9.70(P) | 07/12/2018 |
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Complete List of Directors
Director's Name | Number of Shares Interested | % of issued share capital (%) | Date of Last Notice Filed (Y/M/D) |
---|
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool